The biology of VEGF and its receptors.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12778165.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. VEGF has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions. The biological effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties. Non-signaling co-receptors also modulate VEGF RTK signaling. Currently, several VEGF inhibitors are undergoing clinical testing in several malignancies. VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.
Medical subject headings
- Endothelial Growth Factors
- Intercellular Signaling Peptides and Proteins
- Lymphokines
- Neovascularization, Pathologic
- Neovascularization, Physiologic
- Receptors, Vascular Endothelial Growth Factor
- Signal Transduction